VSBC / VitaSpring Biomedical Co. Ltd. - Documents déposés auprès de la SEC, rapport annuel, procuration

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) August 19, 2025 VITASPRING BIOMEDI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) August 19, 2025 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation) 333-216465 (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) August 5, 2025 VITASPRING BIOMEDIC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) August 5, 2025 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation) 333-216465 (Commission File n

August 11, 2025

Exhibit 16.1 August 11, 2025 Securities and Exchange Commission 100 F Street N.E. Washington, D.C.20549 Ladies and Gentlemen: We have read Item 4.01 of VitaSpring Biomedical Co. Ltd.’s Form 8-K dated August 11, 2025, and we agree with the statements set forth in Item 4.01, insofar as they relate to our firm. We have no basis to agree or disagree with the other statements contained therein. Very tr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) August 26, 2022 VITASPRING BIOMEDI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) August 26, 2022 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation) 333-216465 (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-216465 CUSIP NUMBER 92851B 102 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CS

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 VITASPRING BIOMEDICAL CO. LTD. (Exact name of registrant as specified in its charter) Nevada 333-216465 37-1836726 (State or other jurisdiction of incorporation) (Com

Letter from Kho & Patel.

EX-16.1 2 ex161.htm Letter from Kho & Patel, Certified Public Accountants, a Professional Corporation, to the Securities and Exchange Commission, dated January 17, 2023. January 17, 2023 Office of the Chief Accountant Securities and Exchange Commission 460 Fifth Street N. W. Washington, DC 20549 Re: VITASPRING BIOMEDICAL CO. LTD. Commission File Number 333-216465 To Whom It May Concern: We have re

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: October 31, 2022 ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-216465 VITA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-216465 CUSIP NUMBER 92851B 102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: October

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2022 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-216465 VITASPRI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2022 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-216465 VITASPR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) (X) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2022 ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-216465 VITASPRING BIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 31, 2021 [ ] Transition Report pursua

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 31, 2021 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-216465 VITASPRING BIOME

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

NT 10-Q 1 vsbt10-qnt.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: October 31, 2021 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: July 31, 2021 ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-216465 VITASPR

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 7, 2020 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in Charter) NV 333-216465 37-1836726 (State or Other Jurisdiction of Incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: April 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-216465 VITASPRING

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 24, 2021 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in Charter) Nevada 333-216465 37-1836726 (State or Other Jurisdiction of Incorporation) (Commissio

Annual Report -

10-K 1 vsbc10kjan2021.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333

Quarterly Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: October 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-216465 VITASPRI

Entry into a Material Definitive Agreement -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 14, 2020 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in Charter) Nevada 333-216465 37-1836726 (State or Other Jurisdiction of Incorpor

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 24, 2020 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in Charter) Nevada 333-216465 37-1836726 (State or Other Jurisdiction of Incorporation) (Commis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: July 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-216465 VITASPRING

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-216465 CUSIP NUMBER 92851B 102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: July

Unregistered Sales of Equity Securities, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 14, 2020 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in Charter) Nevada 333-216465 37-1836726 (State or Other Jurisdiction of Incorporation) (Commission

Quarterly Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: April 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-216465 VITASPRING

-

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Annual Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-216465 VITASPRING BIOMEDI

-

NT 10-K 1 form12b25.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 333-216465 CUSIP NUMBER 92851B 102 (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR F

Certificate of Amendment of Certificate of Incorporation

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 21, 2020 VITASPRING BIOMEDICAL CO. LTD. (Exact Name of Registrant as Specified in Charter) Nevada 333-216465 37-1836726 (State or Other Jurisdiction of Incorporation) (Commissio

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 21, 2020 SHEMN CORP. (Exact Name of Registrant as Specified in Charter) Nevada 333-216465 37-1836726 (State or Other Jurisdiction of Incorporation) (Commission File Number)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 21, 2020 SHMEN CORP. (Exact Name of Registrant as Specified in Charter) Nevada 333-216465 37-1836726 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 31, 2019 [ ] Transition Report pursua

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 31, 2019 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 333-216465 SHEMN CORP. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2019 [ ] Transition Report pursuant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2019 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 333-216465 SHEMN CORP. (Exact n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2019 [ ] Transition Report pursuant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2019 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 333-216465 SHEMN CORP. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended January 31, 2019 [ ] Transition Report pursuant to Se

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended January 31, 2019 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-216465 SHEMN CORP. (Exact name

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2019 SHEMN CORP. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2019 SHEMN CORP. (Exact Name of Registrant as Specified in its Charter) Nevada 333-216465 37-1836726 (State of Incorporation) (Commission File Number) (IRS Employer Identifi

EX-3.1

Converted by EDGARwiz

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): 12/12/2018 SHEMN CORP. (Exact Nam

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): 12/12/2018 SHEMN CORP. (Exact Name of Registrant as Specified in its Charter) Nevada 333-216465 37-1836726 (State of Incorporation) (Commission File Number) (IRS Employer Identificati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 31, 2018 [ ] Transition Report pursua

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 31, 2018 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 333-216465 SHEMN CORP. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2018 [ ] Transition Report pursuant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2018 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 333-216465 SHEMN CORP. (Exact n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2018 [ ] Transition Report pursuant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2018 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 333-216465 SHEMN CORP. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended January 31, 2018 [ ] Transition Report pursuant to Se

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended January 31, 2018 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-216465 SHEMN CORP. (Exact name

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2018 SHEMN CORP. (Exact name of registra

Converted by EDGARwiz SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2018 SHEMN CORP. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-216465 (Commission File Number) 37-183

BF Borgers CPA PC

BF Borgers CPA PC www.bfbcpa.us May 8, 2018 United States Securities and Exchange Commission Office of the Chief Accountant 100 F Street, N.E. Washington, D.C. 20549 Re: Shemn Corp. Ladies and Gentleman: We have read the statements under item 4.01 in the Form 8-K dated May 8, 2018, of Shemn Corp. (the ?Company?) to be filed with the Securities and Exchange Commission and we agree with such stateme

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: January 31, 2018 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on For

TABLE OF CONTENTS

shemncorp10qoct2017.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 31, 2017 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitio

TABLE OF CONTENTS

shemncorp10q.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2017 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period f

TABLE OF CONTENTS

shemncorp10q042017.htm - Generated by SEC Publisher for SEC Filing . UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2017 [ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Registration Statement on Form S-1/A-5 of our report dated March 2, 2017, relating to the financial statements of Shemn Corp.

Shemn Corp.

Shemn Corp.? Baiyun District, Fuli Taiyuan A9, 904 Guangzhou, China 510165 June 5, 2017 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Acceleration Request of Shemn Corp.? Form S-1 Registration Statement (File No. 333-216465) To Whom It May Concern: Pursuant Rule 461 of the Securities Act of 1933, we hereby request an ac

April 27, 2017

April 27, 2017 Sun Kui President Shemn Corp. Baiyun District, Fuli Taiyuan A9, 904 Guagnzhou, China 510165 Re: Shemn Corp. Registration Statement on Form S-1 Amendment 3 Filed April 12, 2017 File No. 333-216465 Dear Ladies and Gentlemen: This letter sets forth the responses of Shemn Corp. (?Company?) to the letter of the reviewing staff of the Securities and Exchange Commission (the ?Staff?) in co

As filed with the Securities and Exchange Commission on April 27, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment 4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regu

Registration No. 333-216465 As filed with the Securities and Exchange Commission on April 27, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment 4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regulation S-K. SHEMN CORP. (Exact name of registrant as specified in its charter) Nevada (State or Other Jurisdiction of Inco

April 19, 2017

responseletter.htm - Generated by SEC Publisher for SEC Filing April 19, 2017 Sun Kui President Shemn Corp. Baiyun District, Fuli Taiyuan A9, 904 Guagnzhou, China 510165 Re: Shemn Corp. Registration Statement on Form S-1 Amendment 2 Filed April 12, 2017 File No. 333-216465 Dear Ladies and Gentlemen: This letter sets forth the responses of Shemn Corp. (“Company”) to the letter of the reviewing staf

As filed with the Securities and Exchange Commission on April 19, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regu

shemncorps1a3.htm - Generated by SEC Publisher for SEC Filing Registration No. 333-216465 As filed with the Securities and Exchange Commission on April 19, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regulation S-K. SHEMN CORP. (Exact name of registrant as specifi

SALES CONTRACT

salescontratct.htm - Generated by SEC Publisher for SEC Filing SALES CONTRACT Nr. 1702-2017, dated February 17, 2017 China This Sales Contract (“Contract”) is made between Guangzhou Accessories Ltd., hereinafter referred to as “Buyer” and Shemn Corp. a legal entity duly registered and existing under the laws of the State of Nevada, United States of America, hereinafter referred to as “Seller” HAVE

April 12, 2017

April 12, 2017 Sun Kui? President?Shemn Corp.? Baiyun District, Fuli Taiyuan A9, 904 Guagnzhou, China 510165 Re: Shemn Corp.? Registration Statement on Form S-1 Amendment 1 Filed March 30, 2017? File No. 333-216465 Dear Ladies and Gentlemen: This letter sets forth the responses of Shemn Corp. (?Company?) to the letter of the reviewing staff of the Securities and Exchange Commission (the ?Staff?) i

As filed with the Securities and Exchange Commission on April 12, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regu

shemns1a2.htm - Generated by SEC Publisher for SEC Filing Registration No. 333-216465 As filed with the Securities and Exchange Commission on April 12, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regulation S-K. SHEMN CORP. (Exact name of registrant as specified i

Shemn Corp. Subscription Agreement The undersigned, intending to be legally bound, hereby irrevocably subscribes for and agrees to purchase ____________ shares of the common stock of Shemn Corp., a Nevada corporation, placed in China (the ?Company?),

Shemn Corp. Subscription Agreement The undersigned, intending to be legally bound, hereby irrevocably subscribes for and agrees to purchase shares of the common stock of Shemn Corp., a Nevada corporation, placed in China (the ?Company?), for a purchase price of $, or $0.03 per share. Simultaneous with the execution and delivery of this confirmation to the Company, the undersigned is either deliver

As filed with the Securities and Exchange Commission on March 30, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regu

Registration No. 333- 216465 As filed with the Securities and Exchange Commission on March 30, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regulation S-K. SHEMN CORP. (Exact name of registrant as specified in its charter) Nevada (State or Other Jurisdiction of Inc

SALES CONTRACT

EX-10.5 4 ex105.htm GOODS SALES AGREEMENT WITH SECOND CUSTOMER SALES CONTRACT Nr. 1003-2017, dated March 10, 2017 China This Sales Contract (“Contract”) is made between Guanleather Fashion Accessory Co., Ltd., hereinafter referred to as “Buyer” and Shemn Corp. a legal entity duly registered and existing under the laws of the State of Nevada, United States of America, hereinafter referred to as “Se

March 30, 2017

March 30, 2017 Sun Kui? President?Shemn Corp.? Baiyun District, Fuli Taiyuan A9, 904 Guagnzhou, China 510165 Re: Shemn Corp.? Registration Statement on Form S-1 Filed March 6, 2017? File No. 333-216465 Dear Ladies and Gentlemen: This letter sets forth the responses of Shemn Corp. (?Company?) to the letter of the reviewing staff of the Securities and Exchange Commission (the ?Staff?) in connection

SALES CONTRACT

SALES CONTRACT Nr. 1702-2017, dated February 17, 2017 China This Sales Contract (?Contract?) is made between Guangzhou Accessories Ltd., hereinafter referred to as ?Buyer? and Shemn Corp. a legal entity duly registered and existing under the laws of the State of Nevada, United States of America, hereinafter referred to as ?Seller? HAVE AGREED AS FOLLOWS: I. SUBJECT OF CONTRACT 1.1) According to th

SALES CONTRACT

SALES CONTRACT Nr. 1406-2017, dated March 14, 2017 China This Sales Contract (?Contract?) is made between Doliongol Leather Co., Ltd., hereinafter referred to as ?Buyer? and Shemn Corp. a legal entity duly registered and existing under the laws of the State of Nevada, United States of America, hereinafter referred to as ?Seller? HAVE AGREED AS FOLLOWS: I. SUBJECT OF CONTRACT 1.1) According to this

SALES CONTRACT

EX-10.7 6 ex107.htm GOODS SALES AGREEMENT WITH FORTH CUSTOMER SALES CONTRACT Nr. 2103-2017, dated March 21, 2017 China This Sales Contract (“Contract”) is made between Baggy Lon Dao, Ltd., hereinafter referred to as “Buyer” and Shemn Corp. a legal entity duly registered and existing under the laws of the State of Nevada, United States of America, hereinafter referred to as “Seller” HAVE AGREED AS

As filed with the Securities and Exchange Commission on March 6, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regulation S-K. S

shemncorps-1.htm - Generated by SEC Publisher for SEC Filing Registration No. 333- As filed with the Securities and Exchange Commission on March 6, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Item 501(1)(b)(8)(iii) of Regulation S-K. SHEMN CORP. (Exact name of registrant as specified in its charter) N

Verbal Agreement

Verbal Agreement September 6, 2016 The President of Shem Corp. Sun Kui is verbally confirming the ability to loan to Shemn Corp. funds in the amount of $50,000 USA dollars (fifty thousand USA dollars) for the purpose of the Shemn Corp.?s needs, such as expanses related to the Form S-1 Registration Statement and other necessary provisions in regards to the Shemn Corp.?s business operations. Confirm

EX-3.1

Lease Agreement

EX-10.4 8 ex10-4.htm LEASE AGREEMENT Lease Agreement This Lease Agreement (the “Agreement”), made and entered into on this 27th of January 2017 by and between Wang Yun (“Lessor”) and Shemn Corp. (“Lessee”) collectively referred to as (the “Parties"). The parties agree as follows: Premises: In consideration of the rents to be paid hereunder and the covenants and obligations to be observed by the Le

Shemn Corp. Subscription Agreement The undersigned, intending to be legally bound, hereby irrevocably subscribes for and agrees to purchase ____________ shares of the common stock of Shemn Corp., a Nevada corporation, placed in China (the “Company”),

Shemn Corp. Subscription Agreement The undersigned, intending to be legally bound, hereby irrevocably subscribes for and agrees to purchase shares of the common stock of Shemn Corp., a Nevada corporation, placed in China (the ?Company?), for a purchase price of $, or $0.03 per share. Simultaneous with the execution and delivery of this confirmation to the Company, the undersigned is either deliver

SALES CONTRACT

SALES CONTRACT Nr. 1702-2017, dated February 17, 2017 China This Sales Contract (?Contract?) is made between Guangzhou Accessories Ltd., hereinafter referred to as ?Buyer? and Shemn Corp. a legal entity duly registered and existing under the laws of the State of Nevada, United States of America, hereinafter referred to as ?Seller? HAVE AGREED AS FOLLOWS: I. SUBJECT OF CONTRACT 1.1) According to th

Shemn Corp.

EX-3.2 3 ex3-2.htm BYLAWS Bylaws of Shemn Corp. September 6, 2016 ARTICLE I OFFICES AND CORPORATE SEAL SECTION 1.1 Registered Office. The registered office of SHEMN CORP. (hereinafter the "Corporation") in the State of Nevada shall be c/o Business Filings Incorporated, 701 South Carson Street, Suite #200, Carson City, Nevada 89701. In addition to its registered office, the Corporation shall mainta

EQUIPMENT SALE CONTACT This Equipment sale contract (the ?Agreement?) dated this 5th day of January 2017

EQUIPMENT SALE CONTACT This Equipment sale contract (the ?Agreement?) dated this 5th day of January 2017 BETWEEN: Sewing Equip China Co.